A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control study

ABSTRACT Objective: To investigate the relationship between vitamin D status, using circulating 25-hydroxyvitamin D [25 (OH) D], and renal cell carcinoma (RCC) risk in a case-control study, because the association between the two is unclear in China. Materials and Methods: A total of 135 incident...

Full description

Bibliographic Details
Main Authors: Fei Li, HongFan Zhao, Lina Hou, Fengsheng Ling, Yue Zhang, WanLong Tan
Format: Article
Language:English
Published: Sociedade Brasileira de Urologia
Series:International Brazilian Journal of Urology
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000300523&lng=en&tlng=en
id doaj-ef6e1e44f0bb467983508a9ae25c01a3
record_format Article
spelling doaj-ef6e1e44f0bb467983508a9ae25c01a32020-11-24T20:44:10ZengSociedade Brasileira de UrologiaInternational Brazilian Journal of Urology1677-611945352353010.1590/s1677-5538.ibju.2018.0186S1677-55382019000300523A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control studyFei LiHongFan ZhaoLina HouFengsheng LingYue ZhangWanLong TanABSTRACT Objective: To investigate the relationship between vitamin D status, using circulating 25-hydroxyvitamin D [25 (OH) D], and renal cell carcinoma (RCC) risk in a case-control study, because the association between the two is unclear in China. Materials and Methods: A total of 135 incident RCC cases were matched with 135 controls by age and sex. The blood samples were collected on the first day of hospitalization before surgery to measure plasma 25 (OH) D. Logistic regression analyses were used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs) with adjustment for several confounders (e.g. age, gender, smoking and season of blood draw). Furthermore, the association of RCC with 25 (OH) D in units of 10 ng / mL as a continuous variable were also examined. Results: The average plasma 25 (OH) D concentrations in RCC were significantly lower compared with those of the controls (21.5 ± 7.4 ng / mL vs. 24.1 ± 6.6 ng / mL, respectively; P = 0.003). In the adjusted model, inverse associations were observed between circulating 25 (OH) D levels and RCC risk for 25 (OH) D insufficiency (20-30 ng / mL) with OR of 0.50 (95% CI: 0.29-0.88; P = 0.015) and a normal 25 (OH) D level (≥ 30 ng / mL) with OR of 0.30 (95% CI: 0.13-0.72; P = 0.007), compared with 25 (OH) D deficiency (< 20 ng / mL). Furthermore, results with 25 (OH) D as a linear variable indicated that each 10 ng / mL increment of plasma 25 (OH) D corresponded to a 12% decrease in RCC risk. Conclusions: This case-control study on a Chinese Han population supports the protective effect of a higher circulating concentration of 25 (OH) against RCC, whether the confounding factors are adjusted or not.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000300523&lng=en&tlng=enCarcinoma, Renal CellVitamin D25-Hydroxyvitamin D 2
collection DOAJ
language English
format Article
sources DOAJ
author Fei Li
HongFan Zhao
Lina Hou
Fengsheng Ling
Yue Zhang
WanLong Tan
spellingShingle Fei Li
HongFan Zhao
Lina Hou
Fengsheng Ling
Yue Zhang
WanLong Tan
A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control study
International Brazilian Journal of Urology
Carcinoma, Renal Cell
Vitamin D
25-Hydroxyvitamin D 2
author_facet Fei Li
HongFan Zhao
Lina Hou
Fengsheng Ling
Yue Zhang
WanLong Tan
author_sort Fei Li
title A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control study
title_short A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control study
title_full A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control study
title_fullStr A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control study
title_full_unstemmed A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control study
title_sort higher circulating concentration of 25-hydroxyvitamin-d decreases the risk of renal cell carcinoma: a case-control study
publisher Sociedade Brasileira de Urologia
series International Brazilian Journal of Urology
issn 1677-6119
description ABSTRACT Objective: To investigate the relationship between vitamin D status, using circulating 25-hydroxyvitamin D [25 (OH) D], and renal cell carcinoma (RCC) risk in a case-control study, because the association between the two is unclear in China. Materials and Methods: A total of 135 incident RCC cases were matched with 135 controls by age and sex. The blood samples were collected on the first day of hospitalization before surgery to measure plasma 25 (OH) D. Logistic regression analyses were used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs) with adjustment for several confounders (e.g. age, gender, smoking and season of blood draw). Furthermore, the association of RCC with 25 (OH) D in units of 10 ng / mL as a continuous variable were also examined. Results: The average plasma 25 (OH) D concentrations in RCC were significantly lower compared with those of the controls (21.5 ± 7.4 ng / mL vs. 24.1 ± 6.6 ng / mL, respectively; P = 0.003). In the adjusted model, inverse associations were observed between circulating 25 (OH) D levels and RCC risk for 25 (OH) D insufficiency (20-30 ng / mL) with OR of 0.50 (95% CI: 0.29-0.88; P = 0.015) and a normal 25 (OH) D level (≥ 30 ng / mL) with OR of 0.30 (95% CI: 0.13-0.72; P = 0.007), compared with 25 (OH) D deficiency (< 20 ng / mL). Furthermore, results with 25 (OH) D as a linear variable indicated that each 10 ng / mL increment of plasma 25 (OH) D corresponded to a 12% decrease in RCC risk. Conclusions: This case-control study on a Chinese Han population supports the protective effect of a higher circulating concentration of 25 (OH) against RCC, whether the confounding factors are adjusted or not.
topic Carcinoma, Renal Cell
Vitamin D
25-Hydroxyvitamin D 2
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382019000300523&lng=en&tlng=en
work_keys_str_mv AT feili ahighercirculatingconcentrationof25hydroxyvitaminddecreasestheriskofrenalcellcarcinomaacasecontrolstudy
AT hongfanzhao ahighercirculatingconcentrationof25hydroxyvitaminddecreasestheriskofrenalcellcarcinomaacasecontrolstudy
AT linahou ahighercirculatingconcentrationof25hydroxyvitaminddecreasestheriskofrenalcellcarcinomaacasecontrolstudy
AT fengshengling ahighercirculatingconcentrationof25hydroxyvitaminddecreasestheriskofrenalcellcarcinomaacasecontrolstudy
AT yuezhang ahighercirculatingconcentrationof25hydroxyvitaminddecreasestheriskofrenalcellcarcinomaacasecontrolstudy
AT wanlongtan ahighercirculatingconcentrationof25hydroxyvitaminddecreasestheriskofrenalcellcarcinomaacasecontrolstudy
AT feili highercirculatingconcentrationof25hydroxyvitaminddecreasestheriskofrenalcellcarcinomaacasecontrolstudy
AT hongfanzhao highercirculatingconcentrationof25hydroxyvitaminddecreasestheriskofrenalcellcarcinomaacasecontrolstudy
AT linahou highercirculatingconcentrationof25hydroxyvitaminddecreasestheriskofrenalcellcarcinomaacasecontrolstudy
AT fengshengling highercirculatingconcentrationof25hydroxyvitaminddecreasestheriskofrenalcellcarcinomaacasecontrolstudy
AT yuezhang highercirculatingconcentrationof25hydroxyvitaminddecreasestheriskofrenalcellcarcinomaacasecontrolstudy
AT wanlongtan highercirculatingconcentrationof25hydroxyvitaminddecreasestheriskofrenalcellcarcinomaacasecontrolstudy
_version_ 1716818157047382016